News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • SK Hynix reported a 58% drop in profit.
  • Shares now trade around 5x earnings.
  • Analyst labels the pullback a tactical buy.
  • Trade plan includes an entry, stop, and two time-horizon targets.
  • Recommends SKUU as a hedge or alternative exposure.
  • Position framed as a value-buy setup for contrarian investors.

Latest Articles

TurboGen Announces  Non-Binding Memorandum of Understanding with U.S.-Based Operator of Residential Healthcare Facilities in Advance of Approximately 40 Units of its 80Kw CHP Systems

TurboGen Announces Non-Binding Memorandum of Understanding with U.S.-Based Operator of Residential Healthcare Facilities in Advance of Approximately 40 Units of its 80Kw CHP Systems

TurboGen Ltd., a developer of multifuel microturbine combined heat and power (CHP) systems, announced it has signed a non-binding memorandum of understanding (MOU) with a U.S. operator of residential healthcare facilities. The agreement contemplates the purchase of around 40 units of TurboGen's 80Kw CHP systems to serve those facilities' energy nee…

Artelo Biosciences Announces ART27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity

Artelo Biosciences Announces ART27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity

Artelo Biosciences announced promising nonclinical study results showing that their oral drug ART27.13 achieved approximately 20% weight loss in obese mice, comparable to semaglutide. When combined with semaglutide, ART27.13 doubled weight loss to about 40%. The drug selectively targets peripheral CB1 and CB2 receptors, offering a novel mechanism d…

Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division

Cerenome Appoints Samantha Fowlkes as Vice President and Head of Commercial Sales, CNSide Diagnostics Division

Cerenome, Inc. (Nasdaq: CNSY), a leader in central nervous system (CNS) oncology diagnostics and therapeutics, has appointed Samantha Fowlkes as Vice President and Head of Commercial Sales for its subsidiary CNSide Diagnostics. With her extensive experience in oncology diagnostics and precision medicine, Fowlkes will spearhead commercial expansion …

Arq to Attend Upcoming Investor Conferences

Arq to Attend Upcoming Investor Conferences

Arq, Inc., a NASDAQ-listed environmental technology company specializing in activated carbon products, announced its participation in the Gabelli 4th Annual PFAS Symposium and Water Tower Virtual Investor Conference in late September 2026. Company management will present their latest solutions focused on removing harmful pollutants, with materials …

Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN®

Abeona Therapeutics® Announces Activation of University of Florida Health as Newest Qualified Treatment Center for ZEVASKYN®

Abeona Therapeutics announced the activation of University of Florida Health as the eighth Qualified Treatment Center to administer ZEVASKYN, a groundbreaking autologous gene-modified cellular therapy for treating wounds in patients with recessive dystrophic epidermolysis bullosa (RDEB). This expansion enhances patient access in Florida and the Sou…

Lithuania: Shot-down drone likely headed for Ukraine, president says

Lithuania: Shot-down drone likely headed for Ukraine, president says

Lithuanian authorities say a Gerbera-type drone, shot down over Lithuania by an Italian NATO fighter jet, is believed to have been en route to Ukraine and was deflected by electronic warfare. The Lithuanian president said the incident does not indicate a deliberate attack on Lithuania, and the army is analysing the drone’s electronics to determine …

Jiuzi Holdings Announces New Progress in AI Intelligent Imaging Platform as System Validation and Commercial Deployment Preparations Advance

Jiuzi Holdings Announces New Progress in AI Intelligent Imaging Platform as System Validation and Commercial Deployment Preparations Advance

Jiuzi Holdings, Inc. provides an update on the development progress of its AI intelligent imaging and data platform, focusing on integrating core capabilities, evaluating system stability, enhancing multi-scenario adaptability, and preparing for potential commercial deployment. The company is transitioning from isolated algorithm functions to a uni…

Citi Identifies Three Historical Lessons as Fed Poised to Raise Rates

Citi Identifies Three Historical Lessons as Fed Poised to Raise Rates

Citi economists outline three takeaways for investors as the Federal Reserve is expected to lift interest rates: initial hikes often create short-term equity volatility but are followed by gains over 6-12 months; regional leadership typically shifts away from the U.S. toward Japan, Europe and select emerging markets; and a tilt to value and cyclica…

Kailera Therapeutics to Participate in September Investor Conferences

Kailera Therapeutics to Participate in September Investor Conferences

Kailera Therapeutics, a clinical-stage biotech focused on innovative obesity treatments, will participate in prominent September 2026 investor conferences including Bernstein Insights and Stifel's Cardiometabolic Forum. The company will feature discussions with its leadership on pipeline progress and strategic vision. Kailera is advancing four clin…

Shock Top and Spirit Halloween Brew Up a Scary Good Collaboration

Shock Top and Spirit Halloween Brew Up a Scary Good Collaboration

Tilray Brands, via its Shock Top beer brand, has launched a limited-edition Candy Corn Wheat Ale in collaboration with Spirit Halloween, alongside an exclusive Wedgehead costume available on SpiritHalloween.com. The seasonal offerings aim to capture the Halloween spirit and engage consumers with unique products that blend beverage and retail entert…

Fate Therapeutics Selected for Four Presentations Highlighting its Off-the-Shelf CAR T-Cell Portfolio in Autoimmune Disease at ACR Convergence 2026

Fate Therapeutics Selected for Four Presentations Highlighting its Off-the-Shelf CAR T-Cell Portfolio in Autoimmune Disease at ACR Convergence 2026

Fate Therapeutics announced that four abstracts highlighting clinical and translational research on its off-the-shelf CAR T-cell therapies, including FT819 and FT839, were selected for presentation at the American College of Rheumatology Convergence 2026. Presentations will cover updated clinical data, outpatient administration advances, patient pr…